Xuan et al. 42 found that inhibition of SCD1 and FADS2 could induce ferroptosis, reduce cisplatin resistance, and enhance cisplatin's anti-cancer effect; therefore, inhibition of SCD1 and FADS2 in combination with cisplatin was an effective treatment. This evidence concerns the gene FADS2 and cancer.